BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11449203)

  • 1. Pharmacokinetics of intranasal corticosteroids.
    Szefler SJ
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S26-31. PubMed ID: 11449203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
    Onrust SV; Lamb HM
    Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
    Derendorf H; Meltzer EO
    Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids in the treatment of pediatric allergic rhinitis.
    Scadding GK
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S59-64. PubMed ID: 11449208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis.
    Blaiss MS
    Allergy Asthma Proc; 2011; 32(6):413-8. PubMed ID: 22221434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
    Lumry WR
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis.
    Schenkel E
    Expert Opin Pharmacother; 2003 Sep; 4(9):1579-91. PubMed ID: 12943488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of corticosteroid nasal sprays in relation to concomitant use and cost of other prescription medications to treat allergic rhinitis symptoms: retrospective cohort analysis of pharmacy claims data.
    Garris C; Shah M; D'Souza A; Stanford R
    Clin Drug Investig; 2009; 29(8):515-26. PubMed ID: 19591513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic effects of intranasal steroids: an endocrinologist's perspective.
    Allen DB
    J Allergy Clin Immunol; 2000 Oct; 106(4 Suppl):S179-90. PubMed ID: 11032642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal corticosteroids for allergic rhinitis.
    Trangsrud AJ; Whitaker AL; Small RE
    Pharmacotherapy; 2002 Nov; 22(11):1458-67. PubMed ID: 12432972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis.
    Schafer T; Schnoor M; Wagenmann M; Klimek L; Bachert C
    Rhinology; 2011 Aug; 49(3):272-280. PubMed ID: 21858255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials.
    Dibildox J
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S54-8. PubMed ID: 11449207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients.
    Drouin M; Yang WH; Bertrand B; Van Cauwenberge P; Clement P; Dalby K; Darnell R; Ernst TM; Hébert J; Karlsson G; Luciuk G; Mazza J; Roovers M; Ruoppi P; Seppey M; Stern M; Suonpää J; Sussman G; Tan KY; Tse K; Widjaja P; Jensen P; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):153-60. PubMed ID: 8760782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitis.
    Gawchik SM; Saccar CL
    Drug Saf; 2000 Oct; 23(4):309-22. PubMed ID: 11051218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of glucocorticoids to human nasal tissue in vitro.
    Esmailpour N; Högger P; Rohdewald P
    Int Arch Allergy Immunol; 2000 Jun; 122(2):151-4. PubMed ID: 10878494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
    Schenkel EJ; Skoner DP; Bronsky EA; Miller SD; Pearlman DS; Rooklin A; Rosen JP; Ruff ME; Vandewalker ML; Wanderer A; Damaraju CV; Nolop KB; Mesarina-Wicki B
    Pediatrics; 2000 Feb; 105(2):E22. PubMed ID: 10654982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis.
    Bryson HM; Faulds D
    Drugs; 1992 May; 43(5):760-75. PubMed ID: 1379151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mometasone furoate: a review of its intranasal use in allergic rhinitis.
    Baldwin CM; Scott LJ
    Drugs; 2008; 68(12):1723-39. PubMed ID: 18681494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis.
    Wilson AM; Sims EJ; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):598-604. PubMed ID: 9802367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.